Should people with schizophrenia be offered depot antipsychotics as first line treatment?


Murtada Alsaif reports on a new nationwide Swedish cohort study that explores the real-world effectiveness of oral and depot antipsychotics for people with schizophrenia.

[read the full story...]

Long-acting injectable paliperidone palmitate for schizophrenia


Tracey Roberts summarises a recent RCT of the efficacy and safety of paliperidone palmitate 3-month formulation for patients with schizophrenia.

[read the full story...]